We found no named, citable study of this product or formula. The claim may rest on ingredient research rather than a trial of this product.

Pure Encapsulations Berberine UltraSorb
Checked against public sources between July 21 and July 24, 2026 · LookCloser does not sell or recommend supplements.
Does the marketing hold up?
FDA recall appears in this brand's history. An exact-product recall is a direct signal. A different product from the same firm is company context, not a strike against this item.
“Couldn’t verify” means we looked and found no public proof — not a mark against the product. Most supplement claims cannot be independently verified by anyone, so grey is the normal state of this industry.
What the Supplement Facts panel says
| Berbevis berberine- Indena Phytosome™ complex | 550 mg |
|---|
Printed on the package: Gluten-free · Non-GMO · Hypoallergenic · GMO · GMOst · GFCO.ORG · Gluten Free · FREE FROM GMOs†
We read 1 lines from the package photograph. It is our transcript of the label, not the manufacturer’s panel, and it may be incomplete.
The checks, one by one
1 promise needs a closer look.
△Claimed without support found1
?Couldn’t verify independently1
No named laboratory or lot-specific certificate was found for this exact product. No exact brand product page was available for a document check. NSF, IFOS, USP, and Informed-Sport were not checked in this record. This is a public-evidence limit, not a finding that testing did not occur.
We looked and found no public proof. That does not count against the product.
What is worth knowing.
Headlines first. Open evidence only when you want the source trail.
FDA recall appears in this brand's history
An exact-product recall is a direct signal. A different product from the same firm is company context, not a strike against this item.
Evidence and sources
This recall is not about the product on this page. Pure Encapsulations, Inc. recalled a different product on November 17, 2017. FDA has since closed that case. The recalled item was “Pure Encapsulations Systemic Enzyme Complex DIETARY SUPPLEMENT 180 CAPSULES UPC: 7 66298 00862…”
Locked evidence record →Open the full source-linked findingThe barcode identity checks out · 766298025216.
The barcode matches, so we are checking the right product rather than a look-alike.
Evidence and sources
Open Food Facts resolves 766298025216 to "Berberine UltraSorn" (Pure Encapsulations) — consistent with this listing.
Locked evidence record →Open the full source-linked findingWhat remains open 1
- We have not found a public label filing for this exact product.
These are evidence gaps, not strikes against the product.
Filed address
490 Boston Post Road, Sudbury, MASSACHUSETTS 01776, UNITED STATES
USPTO identifies the public owner or applicant behind this brand wordmark. This does not by itself identify the product manufacturer or prove where the product was made. Open USPTO source ↗
Price check for this exact product
Amazon
Exact UPC/GTIN match$0.86 per labeled serving
matching UPC/GTIN · checked Sep 2, 2026
View on Amazon ↗iHerb
Exact UPC/GTIN match$0.86 per labeled serving
matching UPC/GTIN · checked Jul 24, 2026
View on iHerb ↗Target
Not confirmedWe only show a price when the seller publishes the same barcode as the bottle. We haven’t found that match here.
Search Target ↗Walmart
Not confirmedWe only show a price when the seller publishes the same barcode as the bottle. We haven’t found that match here.
Search Walmart ↗Same UPC/GTIN observed across 2 sellers at the same price at check time.
Reference prices only · no affiliate links · every compared seller must publish the matching UPC/GTIN.
Want to inspect the evidence?
The full report shows every source, the exact unresolved question, and the documentation that would settle it.
Record built September 03, 2026. Sources: source listing observed at check time · USPTO Trademark Search · Keepa exact-listing history · NIH / published research · certification and regulator records where available. LookCloser publishes evidence and gaps; it does not advise for or against any supplement. Evidence-based corrections welcome.